4-hydroxyclomiphene has been researched along with 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione in 1 studies
| Studies (4-hydroxyclomiphene) | Trials (4-hydroxyclomiphene) | Recent Studies (post-2010) (4-hydroxyclomiphene) | Studies (16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione) | Trials (16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione) | Recent Studies (post-2010) (16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione) |
|---|---|---|---|---|---|
| 7 | 0 | 1 | 116 | 0 | 2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koga, M; Musgrove, EA; Sutherland, RL | 1 |
1 other study(ies) available for 4-hydroxyclomiphene and 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione
| Article | Year |
|---|---|
Modulation of the growth-inhibitory effects of progestins and the antiestrogen hydroxyclomiphene on human breast cancer cells by epidermal growth factor and insulin.
Topics: Breast Neoplasms; Cell Division; Clomiphene; Epidermal Growth Factor; Estrogen Antagonists; Female; Growth Inhibitors; Humans; Insulin; Pregnenediones; Progestins; Tumor Cells, Cultured | 1989 |